Dr Agarwals Eye Hospital Ltd Stock Price Today (NSE: DRAGARWQ)
Fundamental Score
Dr Agarwals Eye Hospital Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Dr Agarwals Eye Hospital Ltd share price today is ₹5018.30, down 1.61% on NSE/BSE as of 2 June 2026. Dr Agarwals Eye Hospital Ltd (DRAGARWQ) is a Small-cap company in the Hospital sector with a market capitalisation of ₹2.78K (Cr). The 52-week high for DRAGARWQ share price is ₹6392.00 and the 52-week low is ₹4142.00. At a P/E ratio of 44.20x, DRAGARWQ is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 29.50% and a debt-to-equity ratio of 1.06.
Dr Agarwals Eye Hospital Ltd Share Price Chart — NSE/BSE Historical Performance
Dr Agarwals Eye Hospital Ltd share price chart: 3.19% return over the past month. 52-week high ₹6392.00, 52-week low ₹4142.00.
Dr Agarwals Eye Hospital Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹5124.00 | ₹5169.20 | ₹5105.90 | ₹5110.00 | 19.00 (Cr) | |
| ₹4999.90 | ₹5145.00 | ₹4894.45 | ₹5119.20 | 60.00 (Cr) | |
| ₹5101.15 | ₹5101.15 | ₹4935.00 | ₹4983.95 | 98.00 (Cr) | |
| ₹5106.15 | ₹5200.00 | ₹5084.50 | ₹5150.75 | 210.00 (Cr) | |
| ₹5178.90 | ₹5740.00 | ₹4811.10 | ₹5087.45 | 1.24K (Cr) | |
| ₹5128.40 | ₹5200.00 | ₹5000.00 | ₹5159.05 | 313.00 (Cr) | |
| ₹5112.15 | ₹5136.85 | ₹5084.45 | ₹5121.05 | 44.00 (Cr) | |
| ₹4795.00 | ₹5117.75 | ₹4795.00 | ₹5093.95 | 171.00 (Cr) | |
| ₹5100.05 | ₹5139.60 | ₹5040.00 | ₹5073.35 | 115.00 (Cr) | |
| ₹5070.00 | ₹5170.40 | ₹5050.00 | ₹5082.80 | 369.00 (Cr) |
Dr Agarwals Eye Hospital Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹4983.95 | ₹5740.00 | ₹4795.00 | ₹5110.00 | +2.53% | |
| ₹4879.95 | ₹5200.00 | ₹4612.50 | ₹4983.95 | +2.13% | |
| ₹4460.00 | ₹4990.00 | ₹4425.00 | ₹4699.55 | +5.37% | |
| ₹4626.00 | ₹4950.00 | ₹4498.40 | ₹4599.95 | -0.56% | |
| ₹5340.05 | ₹6392.00 | ₹4412.05 | ₹4650.20 | -12.92% | |
| ₹5772.00 | ₹5840.00 | ₹5099.00 | ₹5334.35 | -7.58% | |
| ₹5384.10 | ₹5890.00 | ₹5013.15 | ₹5735.30 | +6.52% | |
| ₹4820.00 | ₹5650.00 | ₹4750.00 | ₹5235.70 | +8.62% | |
| ₹4490.00 | ₹4880.00 | ₹4350.00 | ₹4859.10 | +8.22% | |
| ₹4360.00 | ₹5449.00 | ₹4231.00 | ₹4472.55 | +2.58% | |
| ₹4522.00 | ₹4780.00 | ₹4280.00 | ₹4381.90 | -3.10% | |
| ₹4411.55 | ₹4562.00 | ₹4142.00 | ₹4522.20 | +2.51% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Overvalued small-cap riding a growth narrative with substantial execution risk; liquidity a concern.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Dr. Agarwal's Health Care submitted its quarterly compliance certificate for Q4 FY26 on April 6, 2026.
CORE STORY (THE REAL GAME)
Dr. Agarwal's is riding the wave of increased demand for specialized eye care in India and internationally, expanding aggressively through new facilities and potential acquisitions. This is a growth story, not a value play.
- Strong Q3 FY26 results with 23% YoY revenue growth
- Aggressive expansion with 38 new facilities in 9 months
- 74.3% YoY PAT growth for 9M'FY26
- Successful integration of new facilities
- Acquisition of smaller players in key markets
- Faster-than-expected growth in international markets
- Small-cap liquidity risk
- High promoter pledge (29.26%)
- Stretched valuation (P/E 44.2x vs. industry 52.84x)
FII increased stake by 0.25%, DII increased stake by 0.05%, Promoter increased stake by 0.77%.
Healthcare sector faces potential cost increases due to geopolitical instability (Iran War impact).
Profit converting to cash - Free Cash Flow 5Y: ₹43.95 Cr
Expect continued growth driven by expansion. Key is managing costs and integrating new facilities. 3-6 month horizon: Monitor expansion progress and profitability.
Primary Thesis Risk
Inability to sustain high growth rates and manage expansion costs will lead to a derating.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Dr Agarwals Eye Hospital Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dr Agarwals Eye Hospital Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of DRAGARWQ across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (29.50%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (17.53%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (28.53%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (36.54%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (15.20%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (17.68% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (32.05% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (32.05% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (6.58x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹43.95 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (72.67%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 44.20x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Elevated Debt Levels (D/E: 1.06)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Limited Institutional Interest (FII+DII: 4.10%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
High Share Pledging Risk (29.26%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
Dr Agarwals Eye Hospital Ltd vs Hospital Peers
Peer Comparison - Hospital
Compare Dr Agarwals Eye Hospital Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Dr Agarwals Eye Hospital LtdDr Agarwals Eye...Selected✓ DRAGARWQ • 526783 | 52.8/100 | ₹5018.30₹5018 | ₹2783.13₹2783.13 | 44.20Average 44.2 Average | 29.50%Excellent 29.50% Excellent | 17.53%Good 17.53% Good | 1.06Average 1.1 Average | 32.05%Excellent 32.05% Excellent | 17.68%Excellent 17.68% Excellent | 0.10% |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 69.1/100 | ₹1068.75₹1069 | ₹109416.28₹109416.28 | 77.65Average 77.7 Average | 12.72%Average 12.72% Average | 14.88%Average 14.88% Average | 0.33Excellent 0.3 Excellent | 80.50%Excellent 80.50% Excellent | 46.01%Excellent 46.01% Excellent | 0.13% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 50.2/100 | ₹8272.50₹8273 | ₹104825.94₹104825.94 | 62.70Average 62.7 Average | 18.42%Good 18.42% Good | 16.64%Good 16.64% Good | 0.88Good 0.9 Good | 33.72%Excellent 33.72% Excellent | 14.15%Good 14.15% Good | 0.26% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 55.6/100 | ₹960.55₹961 | ₹68301.24₹68301.24 | 67.80Average 67.8 Average | 10.13%Average 10.13% Average | 11.96%Average 11.96% Average | 0.34Excellent 0.3 Excellent | 70.31%Excellent 70.31% Excellent | 10.93%Good 10.93% Good | 0.11% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 62.2/100 | ₹1884.10₹1884 | ₹39051.19₹39051.19 | 45.92Average 45.9 Average | 24.22%Excellent 24.22% Excellent | 20.75%Excellent 20.75% Excellent | 0.58Good 0.6 Good | 43.49%Excellent 43.49% Excellent | 11.88%Good 11.88% Good | 0.24% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 15.4/100 | ₹741.25₹741 | ₹34688.15₹34688.15 | 94.51Average 94.5 Average | 8.26%Poor 8.26% Poor | 10.68%Average 10.68% Average | 0.46Excellent 0.5 Excellent | -7.24%Poor -7.24% Poor | -13.71%Poor -13.71% Poor | 0.75% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 61/100 | ₹1240.40₹1240 | ₹33498.00₹33498.00 | 56.03Average 56.0 Average | 16.48%Good 16.48% Good | 19.74%Good 19.74% Good | 0.25Excellent 0.3 Excellent | 70.15%Excellent 70.15% Excellent | 19.73%Excellent 19.73% Excellent | 0.04% |
45.1/100 | ₹741.05₹741 | ₹27605.54₹27605.54 | 83.99Average 84.0 Average | 18.48%Good 18.48% Good | 15.00%Good 15.00% Good | 1.40Average 1.4 Average | 25.01%Excellent 25.01% Excellent | 22.01%Excellent 22.01% Excellent | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 51.2/100 | ₹479.95₹480 | ₹16844.04₹16844.04 | 145.15Average 145.2 Average | 4.76%Poor 4.76% Poor | 9.99%Poor 9.99% Poor | 0.51Good 0.5 Good | 41.72%Excellent 41.72% Excellent | 26.38%Excellent 26.38% Excellent | 0.00% |
Rainbow Childrens Medicare Pvt LtdRainbow Childre... RAINBOW • 543524 | 54.6/100 | ₹1350.70₹1351 | ₹13410.38₹13410.38 | 52.84Average 52.8 Average | 17.43%Good 17.43% Good | 18.69%Good 18.69% Good | 0.54Good 0.5 Good | 33.66%Excellent 33.66% Excellent | 16.08%Excellent 16.08% Excellent | 0.23% |
36.4/100 | ₹646.85₹647 | ₹10474.40₹10474.40 | 296.22Average 296.2 Average | 5.14%Poor 5.14% Poor | 8.56%Poor 8.56% Poor | 1.92Average 1.9 Average | 19.34%Excellent 19.34% Excellent | 15.22%Excellent 15.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Max Healthcare Institute Ltd share price109416.28 Cr
- Apollo Hospitals Enterprise Ltd share price104825.94 Cr
- Fortis Healthcare Ltd share price68301.24 Cr
- Narayana Hrudayalaya Ltd share price39051.19 Cr
- Aster DM Healthcare Ltd share price34688.15 Cr
Dr Agarwals Eye Hospital Ltd PE Ratio History
Historical price-to-earnings ratio for DRAGARWQ — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹116.28 | ₹5334.35 | 45.9x |
| FY 2024 | ₹98.64 | ₹6147.10 | 62.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Dr Agarwals Eye Hospital Ltd Dividend History
Annual cash dividends paid by DRAGARWQ — dividend yield 0.10%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹2.35 Cr |
| FY 2024 | ₹2.58 Cr |
| FY 2023 | ₹1.41 Cr |
| FY 2022 | ₹0.02 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Dr Agarwals Eye Hospital Ltd Quarterly Performance
Latest quarterly metrics for DRAGARWQ — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
15.20%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
36.54%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
17.68%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
32.05%
Compounded annual net profit growth over 5 years
Dr Agarwals Eye Hospital Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for DRAGARWQ — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Dr Agarwals Eye Hospital Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Dr Agarwals Eye Hospital Ltd (DRAGARWQ) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Dr Agarwals Eye Hospital Ltd
About DRAGARWQ (Dr Agarwals Eye Hospital Ltd)
Dr. Agarwals Eye Hospital Ltd is a prominent healthcare institution dedicated to preserving and restoring vision across a wide geographical expanse. Beyond the familiar walls of tr...aditional hospitals, it functions as a network of specialized eye care centers, each a beacon of hope for individuals struggling with visual impairments. The hospital distinguishes itself by combining cutting-edge medical technology with the expertise of a dedicated team of ophthalmologists, surgeons, and support staff. Their commitment extends to every aspect of eye health, from comprehensive diagnostics to intricate surgical procedures, creating a holistic approach that prioritizes patient well-being. This institution stands as a testament to innovation in the realm of ophthalmology, continually pushing the boundaries of what is possible in visual care. The hospital's comprehensive suite of services addresses a spectrum of ocular conditions, catering to both common ailments and complex disorders. They offer advanced treatments for prevalent issues such as cataracts and refractive errors, allowing patients to regain clear sight. In addition, Dr. Agarwals Eye Hospital provides specialized care for more intricate conditions like glaucoma, retinal diseases, and corneal disorders. The hospital uses modern methods to correct the position of the eye and make sure it looks right. Whether it's a routine check-up or a demanding surgical intervention, the focus remains unwavering: to provide personalized treatment plans that cater to the unique needs of each patient. Through their commitment to individualized care, the hospital aims to enhance not only vision but also the overall quality of life. Dr. Agarwals Eye Hospital has made a commitment to worldwide access to quality eye care, therefore, they have geographically diverse practices that demonstrate the organization's broad vision. The business provides a full array of services, bringing excellent eye care to diverse communities in India as well as countries in Africa and the Indian Ocean. Each facility is designed to satisfy the particular requirements of the surrounding region, ensuring that people can obtain top-notch eye care regardless of where they are. By broadening their scope, Dr. Agarwals Eye Hospital solidifies its role as a global leader in ophthalmology, transforming lives and strengthening communities by means of vision.
Company Details
Key Leadership
Corporate Events
DRAGARWQ Share Price: Frequently Asked Questions
What is the current share price of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd (DRAGARWQ) trades at ₹5018.30 on NSE and BSE. Market cap ₹2.78K (Cr). Educational data only.
What is the P/E ratio of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd has a P/E of 44.20x vs industry average 52.84x.
What is the Bull Run score for Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd has a Bull Run score of 52.8/100 based on 25+ financial parameters.
Does Dr Agarwals Eye Hospital Ltd pay dividends?
Dr Agarwals Eye Hospital Ltd has a dividend yield of 0.10%. Past dividends don't guarantee future payments.
What is the ROE of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd has ROE of 29.50%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd has debt-to-equity of 1.06.
Is Dr Agarwals Eye Hospital Ltd a good investment?
Bull Run gives Dr Agarwals Eye Hospital Ltd a score of 52.8/100. This is not investment advice — consult a SEBI-registered advisor.